Abbott Laboratories (ABT)
NYSE · Healthcare
Abbott Laboratories Long Term Debt 2007–2025
Abbott Laboratories annual/quarterly long term debt history from 2007 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Abbott Laboratories long term debt for the quarter ending December 31, 2025 were 12.93B, a 8.47% decrease year-over-year.
- Abbott Laboratories long term debt for 2025 were 12.93B, a 8.47% decrease from 2024.
- Abbott Laboratories long term debt for 2024 were 14.13B, a 3.77% decrease from 2023.
- Abbott Laboratories long term debt for 2023 were 14.68B, a 12.48% decrease from 2022.
- Abbott Laboratories long term debt for 2022 were 16.77B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Abbott Laboratories Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $12,929 |
| 2024 | $14,125 |
| 2023 | $14,679 |
| 2022 | $16,773 |
| 2021 | $18,050 |
| 2020 | $18,534 |
| 2019 | $17,938 |
| 2018 | $19,366 |
| 2017 | $27,718 |
| 2016 | $20,684 |
| 2015 | $5,874 |
| 2014 | $3,448 |
| 2013 | $3,397 |
| 2012 | $18,394 |
| 2011 | $13,067 |
| Abbott Laboratories Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $12,929 |
| 2024-12-31 | $14,125 |
| 2023-12-31 | $14,679 |
| 2022-12-31 | $16,773 |
| 2021-12-31 | $18,050 |
| 2020-12-31 | $18,534 |
| 2019-12-31 | $17,938 |
| 2018-12-31 | $19,366 |
| 2017-12-31 | $27,718 |
| 2016-12-31 | $20,684 |
| 2015-12-31 | $5,874 |
| 2014-12-31 | $3,448 |
| 2013-12-31 | $3,397 |
| 2012-12-31 | $18,394 |
| 2011-12-31 | $13,067 |
| 2010-12-31 | $14,569 |
| 2009-12-31 | $11,477 |
| 2008-12-31 | $9,754 |
| 2007-12-31 | $9,488 |
Abbott Laboratories Long Term Debt — FAQ
Abbott Laboratories (ABT) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABT's long term debt history?
The chart and table above show Abbott Laboratories's long term debt by year and by quarter, including the growth rate.